Ah, the age-old dream of cheating death—now with a tech twist courtesy of the world's billionaires and strongmen. When Xi Jinping and Vladimir Putin whisper about living forever, it's less 'et tu, Brute?' and more 'eternal you, biotech?' This piece dives into how the ultra-wealthy are treating aging like a pesky software bug: deploy AI, crunch some data, and voilà, indefinite延寿. It's fascinating, really—AI's supercharging medical research by sifting through genomes faster than a caffeinated coder debugging at 3 a.m.
But let's pump the brakes on the sci-fi hype. Sure, innovations like AI-driven drug discovery (think AlphaFold predicting protein structures) are game-changers, potentially extending healthy lifespans. Imagine personalized treatments that nip age-related diseases in the bud, not just slapping on band-aids. Pro-innovation? Absolutely—democratizing this could mean grandma outliving her grandkids' college debt. Yet, pragmatism check: this immortality quest is gated for the rich right now. While Putin's pondering eternal rule, the rest of us are stuck with kale smoothies and sporadic gym visits.
Humor me here: if aging's a 'technical problem,' who's the engineer? AI might optimize the blueprint, but it can't rewrite the human condition overnight—or even in a decade. We should cheer the R&D push, but critically ask: Will these breakthroughs trickle down, or stay in the oligarch's vault? It's a reminder to innovate inclusively, lest we end up with a world where only the powerful get plot twists in their life stories. Exciting times, folks—stay skeptical, stay curious. Source: Artificial intelligence (AI) | Technology
